These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
198 related articles for article (PubMed ID: 10645226)
1. Prognostic value of tumour associated antigen immunoreactivity and apoptosis in cerebral glioblastomas: an analysis of 168 cases. Korshunov A; Golanov A; Sycheva R; Pronin I J Clin Pathol; 1999 Aug; 52(8):574-80. PubMed ID: 10645226 [TBL] [Abstract][Full Text] [Related]
2. Immunohistochemical markers for prognosis of cerebral glioblastomas. Korshunov A; Golanov A; Sycheva R J Neurooncol; 2002 Jul; 58(3):217-36. PubMed ID: 12187957 [TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of Ki67, p53 and epidermal growth factor receptor immunostaining in human glioblastomas. Bouvier-Labit C; Chinot O; Ochi C; Gambarelli D; Dufour H; Figarella-Branger D Neuropathol Appl Neurobiol; 1998 Oct; 24(5):381-8. PubMed ID: 9821169 [TBL] [Abstract][Full Text] [Related]
4. [The prognostic importance of cancer-associated proteins and apoptosis in glioblastomas of the cerebral hemispheres]. Korshunov AG; Golanov AV; Sycheva RV; Pronin IN Zh Vopr Neirokhir Im N N Burdenko; 1999; (1):3-7. PubMed ID: 10335568 [TBL] [Abstract][Full Text] [Related]
5. MDM2 and p53 expression in gliomas: a multivariate survival analysis including proliferation markers and epidermal growth factor receptor. Korkolopoulou P; Christodoulou P; Kouzelis K; Hadjiyannakis M; Priftis A; Stamoulis G; Seretis A; Thomas-Tsagli E Br J Cancer; 1997; 75(9):1269-78. PubMed ID: 9155045 [TBL] [Abstract][Full Text] [Related]
6. Expression of p53, EGFR, pRb and bcl-2 proteins in pediatric glioblastoma multiforme: a study of 54 patients. Ganigi PM; Santosh V; Anandh B; Chandramouli BA; Sastry Kolluri VR Pediatr Neurosurg; 2005; 41(6):292-9. PubMed ID: 16293948 [TBL] [Abstract][Full Text] [Related]
7. The role of apoptosis, cell proliferation index, bcl-2, and p53 in glioblastoma prognosis. Ribeiro Mde C; Coutinho LM; Hilbig A Arq Neuropsiquiatr; 2004 Jun; 62(2A):262-70. PubMed ID: 15235729 [TBL] [Abstract][Full Text] [Related]
8. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2. Haitel A; Posch B; El-Baz M; Mokhtar AA; Susani M; Ghoneim MA; Marberger M J Urol; 2001 May; 165(5):1481-7. PubMed ID: 11342901 [TBL] [Abstract][Full Text] [Related]
9. Evaluation of cell proliferation, epidermal growth factor receptor, and bcl-2 immunoexpression as prognostic factors for patients with World Health Organization grade 2 oligodendroglioma. Reis-Filho JS; Faoro LN; Carrilho C; Bleggi-Torres LF; Schmitt FC Cancer; 2000 Feb; 88(4):862-9. PubMed ID: 10679656 [TBL] [Abstract][Full Text] [Related]
10. Hepatocellular carcinomas with a high proliferation index and a low degree of apoptosis and necrosis are associated with a shortened survival. Soini Y; Virkajärvi N; Lehto VP; Pääkkö P Br J Cancer; 1996 May; 73(9):1025-30. PubMed ID: 8624258 [TBL] [Abstract][Full Text] [Related]
11. Prognostic relevance of p53 protein expression in glioblastoma. Birner P; Piribauer M; Fischer I; Gatterbauer B; Marosi C; Ungersböck K; Rössler K; Budka H; Hainfellner JA Oncol Rep; 2002; 9(4):703-7. PubMed ID: 12066196 [TBL] [Abstract][Full Text] [Related]
12. Analysis of complex relationships between age, p53, epidermal growth factor receptor, and survival in glioblastoma patients. Simmons ML; Lamborn KR; Takahashi M; Chen P; Israel MA; Berger MS; Godfrey T; Nigro J; Prados M; Chang S; Barker FG; Aldape K Cancer Res; 2001 Feb; 61(3):1122-8. PubMed ID: 11221842 [TBL] [Abstract][Full Text] [Related]
13. A comparative study of apoptosis and proliferation in germinoma and glioblastoma. Mizoguchi M; Inamura T; Shono T; Ikezaki K; Inoha S; Ohgami S; Fukui M Neuro Oncol; 2000 Apr; 2(2):96-102. PubMed ID: 11303626 [TBL] [Abstract][Full Text] [Related]
14. Apoptosis in epithelial ovarian tumours Prognostic significance of clinical and histopathologic factors and its association with the immunohistochemical expression of apoptotic regulatory proteins (p53, bcl-2 and bax). de la Torre FJ; García A; Gil-Moreno A; Planaguma J; Reventos J; Ramón y Cajal S; Xercavins J Eur J Obstet Gynecol Reprod Biol; 2007 Jan; 130(1):121-8. PubMed ID: 16876311 [TBL] [Abstract][Full Text] [Related]
15. Apoptosis and cell-cycle regulatory proteins in colorectal carcinoma: relationship to tumour stage and patient survival. Elkablawy MA; Maxwell P; Williamson K; Anderson N; Hamilton PW J Pathol; 2001 Aug; 194(4):436-43. PubMed ID: 11523051 [TBL] [Abstract][Full Text] [Related]
16. Clinical significance of apoptosis-related factors p53, Mdm2, and Bcl-2 in advanced ovarian cancer. Baekelandt M; Kristensen GB; Nesland JM; Tropé CG; Holm R J Clin Oncol; 1999 Jul; 17(7):2061. PubMed ID: 10561259 [TBL] [Abstract][Full Text] [Related]
17. Expression of biomarkers (p53, transforming growth factor alpha, epidermal growth factor receptor, c-erbB-2/neu and the proliferative cell nuclear antigen) in oropharyngeal squamous cell carcinomas. Ibrahim SO; Lillehaug JR; Johannessen AC; Liavaag PG; Nilsen R; Vasstrand EN Oral Oncol; 1999 May; 35(3):302-13. PubMed ID: 10621852 [TBL] [Abstract][Full Text] [Related]